These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 29953543)
1. Crystal structure of the C-terminal four-helix bundle of the potassium channel KCa3.1. Ji T; Corbalán-García S; Hubbard SR PLoS One; 2018; 13(6):e0199942. PubMed ID: 29953543 [TBL] [Abstract][Full Text] [Related]
2. Histidine phosphorylation relieves copper inhibition in the mammalian potassium channel KCa3.1. Srivastava S; Panda S; Li Z; Fuhs SR; Hunter T; Thiele DJ; Hubbard SR; Skolnik EY Elife; 2016 Aug; 5():. PubMed ID: 27542194 [TBL] [Abstract][Full Text] [Related]
3. Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1- Brown BM; Shim H; Zhang M; Yarov-Yarovoy V; Wulff H Mol Pharmacol; 2017 Oct; 92(4):469-480. PubMed ID: 28760780 [TBL] [Abstract][Full Text] [Related]
4. Contribution of the KCa3.1 channel-calmodulin interactions to the regulation of the KCa3.1 gating process. Morales P; Garneau L; Klein H; Lavoie MF; Parent L; Sauvé R J Gen Physiol; 2013 Jul; 142(1):37-60. PubMed ID: 23797421 [TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1. Srivastava S; Choudhury P; Li Z; Liu G; Nadkarni V; Ko K; Coetzee WA; Skolnik EY Mol Biol Cell; 2006 Jan; 17(1):146-54. PubMed ID: 16251351 [TBL] [Abstract][Full Text] [Related]
6. Channelopathy of small- and intermediate-conductance Ca Nam YW; Downey M; Rahman MA; Cui M; Zhang M Acta Pharmacol Sin; 2023 Feb; 44(2):259-267. PubMed ID: 35715699 [TBL] [Abstract][Full Text] [Related]
7. Toward the rational design of constitutively active KCa3.1 mutant channels. Garneau L; Klein H; Parent L; Sauvé R Methods Enzymol; 2010; 485():437-57. PubMed ID: 21050931 [TBL] [Abstract][Full Text] [Related]
8. Laminar shear stress upregulates endothelial Ca²⁺-activated K⁺ channels KCa2.3 and KCa3.1 via a Ca²⁺/calmodulin-dependent protein kinase kinase/Akt/p300 cascade. Takai J; Santu A; Zheng H; Koh SD; Ohta M; Filimban LM; Lemaître V; Teraoka R; Jo H; Miura H Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H484-93. PubMed ID: 23792675 [TBL] [Abstract][Full Text] [Related]
9. Aromatic-aromatic interactions between residues in KCa3.1 pore helix and S5 transmembrane segment control the channel gating process. Garneau L; Klein H; Lavoie MF; Brochiero E; Parent L; Sauvé R J Gen Physiol; 2014 Feb; 143(2):289-307. PubMed ID: 24470490 [TBL] [Abstract][Full Text] [Related]
11. New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1. Coleman N; Brown BM; Oliván-Viguera A; Singh V; Olmstead MM; Valero MS; Köhler R; Wulff H Mol Pharmacol; 2014 Sep; 86(3):342-57. PubMed ID: 24958817 [TBL] [Abstract][Full Text] [Related]
12. Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels. Brown BM; Shim H; Christophersen P; Wulff H Annu Rev Pharmacol Toxicol; 2020 Jan; 60():219-240. PubMed ID: 31337271 [TBL] [Abstract][Full Text] [Related]
13. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Sankaranarayanan A; Raman G; Busch C; Schultz T; Zimin PI; Hoyer J; Köhler R; Wulff H Mol Pharmacol; 2009 Feb; 75(2):281-95. PubMed ID: 18955585 [TBL] [Abstract][Full Text] [Related]
14. PKA reduces the rat and human KCa3.1 current, CaM binding, and Ca2+ signaling, which requires Ser332/334 in the CaM-binding C terminus. Wong R; Schlichter LC J Neurosci; 2014 Oct; 34(40):13371-83. PubMed ID: 25274816 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1). Christophersen P; Wulff H Channels (Austin); 2015; 9(6):336-43. PubMed ID: 26217968 [TBL] [Abstract][Full Text] [Related]
16. Channelopathy-causing mutations in the S Orfali R; Nam YW; Nguyen HM; Rahman MA; Yang G; Cui M; Wulff H; Zhang M Cell Calcium; 2022 Mar; 102():102538. PubMed ID: 35030515 [TBL] [Abstract][Full Text] [Related]
17. Histidine phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate kinase B is required for activation of KCa3.1 and CD4 T cells. Srivastava S; Li Z; Ko K; Choudhury P; Albaqumi M; Johnson AK; Yan Y; Backer JM; Unutmaz D; Coetzee WA; Skolnik EY Mol Cell; 2006 Dec; 24(5):665-675. PubMed ID: 17157250 [TBL] [Abstract][Full Text] [Related]
18. Structural determinants of the closed KCa3.1 channel pore in relation to channel gating: results from a substituted cysteine accessibility analysis. Klein H; Garneau L; Banderali U; Simoes M; Parent L; Sauvé R J Gen Physiol; 2007 Apr; 129(4):299-315. PubMed ID: 17353352 [TBL] [Abstract][Full Text] [Related]
19. The Trials and Tribulations of Structure Assisted Design of K Shim H; Brown BM; Singh L; Singh V; Fettinger JC; Yarov-Yarovoy V; Wulff H Front Pharmacol; 2019; 10():972. PubMed ID: 31616290 [TBL] [Abstract][Full Text] [Related]
20. Hydrophobic interactions as key determinants to the KCa3.1 channel closed configuration. An analysis of KCa3.1 mutants constitutively active in zero Ca2+. Garneau L; Klein H; Banderali U; Longprá-Lauzon A; Parent L; Sauvá R J Biol Chem; 2009 Jan; 284(1):389-403. PubMed ID: 18996847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]